Please login to the form below

Not currently logged in
Email:
Password:
From: Research

Boehringer lines up biosimilars of major drugs

Humira - AbbottProspects include copies of Humira, Avastin and MabThera

From: Sales

NICE gives partial backing to Ferring's prostate cancer drug

National Institute for Health and Care Excellence NICE logoFirmagon on course for use on NHS in England and Wales

From: Sales

Reckitt Benckiser may spin out pharma division

Reckitt BenckiserMoves to focus on consumer health and household goods

From: Research

Boehringer plans to open trial data back to 1998

Boehringer Ingelheim headquartersWill partner with Sanofi, GSK, Roche, Novartis and ViiV Healthcare on online platform

Tuberculosis: treatment and prevention

One of the most significant global diseases, effective new TB therapies are sorely needed

This month in 1917: A tale of two Mercks

US enters World War I severing ties between Merck & Co and its German parent

European Commission launches mHealth consultation

May lead to policy action by 2015

Mobile device

Ogilvy HealthPR appoints social media manager

Rebecca Canvin joins from Brandcast Media/ Health

Rebecca Convin

Integrating multichannel marketing

External forces are driving the need for pharma to use a greater variety of channels to reach customers

Evidence-based Adherence Strategies

Free Digital Futures Webinar

Google Glass enters Parkinson's trials

The smart glasses' potential will be evaluated as a patient assistant aid

Google Glass

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield Commercial & Medical Services

Ashfield Commercial & Medical Services, part of UDG Healthcare plc, is a leading international provider of services to healthcare manufactures...

Latest intelligence

Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....